The Asia Pacific Veterinary Point of Care Blood Gas Analyzers Market would witness market growth of 6.1% CAGR during the forecast period (2018 – 2024).
Veterinary blood gas analyzer are used in measuring pH levels, blood gases, electrolytes, and metabolites parameters in the blood specimen. Blood gas analyzers have grown popular as diagnosing and monitoring tools. Growing inclination towards owning companion animals, technological advancements in the blood gas analyzers, growing awareness about animal health, increasing expenditures on animal welfare are the factors that drive the growth of the veterinary point of care blood gas analyzers market. Veterinary blood gas analyzers offer convenient testing options and also facilitate rapid diagnosis. Acid-base and respiratory issues are some of the common issues among hospitalized animals. Additionally, growing number of veterinary clinics and availability of affordable blood gas analyzers to private veterinary clinics further ads to the market growth.
Based on Animal, the market is segmented into Companion Animals, Poultry & Dairy Animals, Livestock Animals and Others. Based on Modality, the market is segmented into Portable Analyzers and Handheld Analyzers. Based on End User, the market is segmented into Veterinary Clinics, Veterinary Laboratories, Research Laboratories, and Other End User. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Heska Corporation, Vepalabs (Greencross Ltd.), Nova Biomedical, LifeHealth, LLC., Abaxis, Inc. (Zoetis Inc.), F. Hoffmann-La Roche AG, Bayer AG, Siemens Healthcare, OPTI Medical Systems Inc. (IDEXX Lab) and Radiometer Medical ApS.